adalimumab
US/ˌeɪ.dəˈlɪm.jəˌmæb/
adalimumab noun: an immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor.
Noun
adalimumab (uncountable)
- An immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor.
Origin of adalimumab
From ada- (of unknown origin) + -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”).
Questions about adalimumab
- What does adalimumab mean?
- Adalimumab means an immunosuppressive drug (trademark Humira) that is a genetically engineered monoclonal antibody administered by subcutaneous injection to treat the symptoms of various autoimmune diseases (such as rheumatoid arthritis, Crohn's disease, and psoriasis). It acts by binding to and blocking the activity of tumor necrosis factor.
- What part of speech is adalimumab?
- Adalimumab is a noun.
- How do you pronounce adalimumab?
- Adalimumab is pronounced /ˌeɪ.dəˈlɪm.jəˌmæb/ (US).
Words near adalimumab in the dictionary
Source and license
Adapted from Wiktionary: adalimumab (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “adalimumab.” Word.ws, https://word.ws/adalimumab. Based on Wiktionary, CC BY-SA 4.0.
